Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
•
Primary Care
•
Internal Medicine
How would you approach hormone replacement therapy for perimenopause in a patients with increased risk factors for VTE (hereditary thrombophilia without personal thrombosis, family history of thrombophilia or thrombosis, etc)?
Related Questions
Is there any benefit of using aspirin to mitigate VTE risk in testosterone-induced polycythemia?
Would you evaluate for thrombophilia in patients with incidental splenic infarcts in the setting of known cirrhosis, portal hypertension, and splenomegaly?
How do you start and manage therapeutic SC heparin for acute thrombosis in pregnancy as the patient approaches delivery?
How would you manage superficial thrombophlebitis of the great saphenous vein involving the knee and calf?
How would you manage symptomatic, bilateral subsegmental PE developed after long air travel?
What is your approach to symptomatic superficial thrombosis of the pelvic veins occurring in the immediate postpartum period?
How long would you anticoagulate for PE developed after air travel in a woman on an estrogen-containing vaginal ring for contraception?
How would you manage distal DVT in first trimester of pregnancy?
How would you manage elevated vWF and FVIII levels in a patient with a family history of coagulopathy?
What is your clinical threshold for treating a potential monoclonal gammopathy of thrombotic significance?
